About PharmInvent
PharmInvent is a Healthcare company based in Prague (Czechia) founded in 2010, and was acquired by Ergomed in November 2016. Pharmacovigilance and regulatory services are provided to pharmaceutical firms. Its focus areas include Biopharma Outsourcing, Consulting and Regulatory Affairs. Its legal entity is Pharminvent regulatory s.r.o.
Company details
PharmInvent offers pharmacovigilance and regulatory consulting services to Health Authorities, Pharmaceutical, Biotech and Medical Device companies. The company claims to have experts in the field of Regulatory Science, Clinical Development, and Pharmacovigilance. Pharmacovigilance services include pharmacovigilance outsourcing services (Includes Data Management, Signal Management, Risk Management, SOPs, audits, inspection support etc), establishment and maintenance of pharmacovigilance systems, and safety management in clinical trials. PharmInvent also offers regulatory and medical writing services. The company was acquired by Ergomed in December 2016. The company offers its services in Europe, US, Mexico, South America, Australia, South Africa, Russia and the CIS region.
- Headquarters Prague, Czechia
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website pharminvent.com
- Social LinkedIn X Facebook
- Acquired by Ergomed (Nov 2016)
- Legal Name Pharminvent Regulatory S.R.O.
Investors in PharmInvent
PharmInvent has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ergomed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical CRO services for oncology and rare diseases are provided. | 1997 | ergomedplc.com | Guildford, United Kingdom |
Investor details for PharmInvent
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of PharmInvent
2 dated milestones of PharmInvent across 6 years, from founding to its latest funding, stage changes and deals.
- Founded PharmInvent is founded.
- Exit Acquired by Ergomed.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pharminvent
Complete news archive for PharmInvent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PharmInvent
PharmInvent was founded in 2010.
PharmInvent is headquartered in Prague, Czechia.
PharmInvent offers pharmacovigilance and regulatory consulting services to Health Authorities, Pharmaceutical, Biotech and Medical Device companies. The company claims to have experts in the field of Regulatory Science, Clinical Development, and Pharmacovigilance. Pharmacovigilance services include pharmacovigilance outsourcing services (Includes Data Management, Signal Management, Risk Management, SOPs, audits, inspection support etc), establishment and maintenance of pharmacovigilance systems, and safety management in clinical trials. PharmInvent also offers regulatory and medical writing services. The company was acquired by Ergomed in December 2016. The company offers its services in Europe, US, Mexico, South America, Australia, South Africa, Russia and the CIS region.
PharmInvent has 1 investor. Key investors include Ergomed.
PharmInvent operates through Pharminvent Regulatory S.R.O..
Yes. PharmInvent was acquired by Ergomed in November 2016.

